Bernstein cuts Northrop Grumman stock price target on defense rotation By Investing.com

Bernstein SocGen cut Northrop Grumman’s price target to $660 from $765 while keeping a Market Perform rating, citing a 25% share decline since the Iran war began and a 10% drop since earnings. The company’s Q1 results were solid with EPS and revenue above consensus, but margins came in below estimates and the stock now trades at $542.07, about 30% below its 52-week high. Guidance was largely unchanged aside from higher B-21 capex, while Bernstein slightly raised 2026-27 EPS estimates.

Analysis

The market is treating the latest defense read-through as a valuation reset rather than a fundamental deterioration, but the more important signal is that order visibility is improving faster than sentiment. A 1.4x book-to-bill in a business this concentrated implies backlog quality is still outrunning execution issues, which usually matters more for the next 12-18 months than a single quarter’s margin miss. The downgrade and target-cut look like capitulation to near-term headline risk, not a thesis that demand has rolled over.

The second-order winner is likely the broader defense supply chain, not just prime contractors. If one major prime is being repriced lower despite stable guidance, subcontractors and electronics/niche payload providers with cleaner execution can attract incremental capital as investors search for defense exposure without the same margin and program-concentration overhang. The B-21 capex step-up is also a tell: higher near-term spend typically squeezes FCF optics before it translates into later revenue, so the next catalyst is not demand, it is proof that the cash conversion trough is temporary.

The main risk is time horizon mismatch. Over the next few weeks, the stock can stay weak if rates remain sticky and the tape keeps favoring lower-duration, less capex-intensive names; over the next 6-12 months, incremental missile-defense, drone, and space budgets should matter more than near-term pricing noise. If rates stabilize and management reinforces FCF discipline on the next call, the current multiple already prices in a meaningfully harsher outcome than the guidance actually suggests.

Consensus may be underestimating how much of the selloff is technical and how much capital is waiting for confirmation. With the stock already deeply washed out relative to recent highs, the setup favors a mean-reversion trade once the next contract award or guide-maintenance event removes uncertainty. The asymmetry is better on the upside if earnings revisions keep drifting modestly higher while the market is still anchored to the recent de-rating.

Key Decisions for Investors

• Long NOC for a 1-3 month mean-reversion trade, sized modestly; upside is a retrace toward the revised target area if the next catalyst confirms guidance durability, while downside is limited unless FCF guidance breaks.
• Buy NOC Jan/Apr call spreads rather than stock to express a rebound in sentiment; the implied move is likely cheaper than the stock’s recent realized volatility, preserving convexity if the de-rating overshot.
• Pair trade: long NOC / short a higher-multiple industrial with weaker backlog visibility over the next 2-4 months; the thesis is that defense cash flows re-rate slower, but fundamentals are materially more durable.
• Rotate incremental capital toward defense suppliers with lower capex intensity and clearer program exposure on any further NOC weakness; the second-order trade is to own the picks-and-shovels names if primes remain range-bound.
• Set a catalyst trigger: add to NOC if management reaffirms free-cash-flow guidance or raises backlog/awards commentary on the next earnings cycle; if FCF is cut, exit quickly because the valuation floor likely shifts lower.